PDCI Market Access Inc. is pleased to announce a new Strategic Partnership with Goeree Consulting Ltd (owned and operated by Ron Goeree). Goeree Consulting and PDCI are bringing together an exceptional level of experience and expertise in health economics, while further expanding our resources for clients.
About Ron Goeree
Prior to starting his own firm, Mr. Goeree spent more than 30 years as a professor and economic researcher at McMaster University, where he currently holds the distinction of Professor Emeritus. His most recent prior position was in the Department of Clinical Epidemiology and Biostatistics.
Mr. Goeree is well-regarded as a national and international expert in drug and device reimbursement submissions. He brings more than 15 years of experience working as an external reviewer with the Canadian Agency for Drugs and Technologies in Health’s (CADTH) Common Drug Review (CDR) program; and 10 years working with the Ontario Public Drug Program (OPDP). Mr. Goeree has served on over 150 national and international Advisory Boards for pharmaceutical companies and has published over 500 books, chapters, articles and abstracts in Health Technology Assessment (HTA). In addition to his advisory work, Mr. Goeree is also co-editor of Value in Health, the official journal of ISPOR, and is an editorial board member of the Journal of Medical Economics.
Partnership Between Ron Goeree and PDCI Market Access
PDCI prides itself on being the only Canadian consulting firm offering core competencies and expertise across the entire spectrum of market access, from pricing to reimbursement strategies. Our HTA team, which is comprised of former CADTH members, along with graduate-level health economists and clinical consultants, creates made-in-Canada health economic solutions for all Canadian drug submissions. Our Health Economic (HE) team has experience developing and adapting cost-utility analyses, and other HE models and reports for submission to CDR, pCODR, INESSS and the Private Payer. Mr. Goeree will be working closely with our team of HE experts.
This partnership is exciting for both parties; and, it demonstrates PDCI’s unyielding commitment to be the most valued and trusted pricing and reimbursement partner for our clients.
Please reach out to Donna Lawrence, Director, HTA & HE (905-902-1568; firstname.lastname@example.org) or Ron Goeree, Professor Emeritus and PDCI partner (289.339.7284; email@example.com) to learn more about how we can support your HTA and Health Economic needs.